The endothelium and vascular inflammation in diabetes
Open Access
- 24 June 2007
- journal article
- review article
- Published by SAGE Publications in Diabetes and Vascular Disease Research
- Vol. 4 (2), 84-88
- https://doi.org/10.3132/dvdr.2007.025
Abstract
The endothelium releases multiple mediators, not only regulators of vasomotor function but also important physiological and pathophysiological inflammatory mediators. Endothelial dysfunction is caused by chronic exposure to various stressors such as oxidative stress and modified low-density lipoprotein (LDL) cholesterol, resulting in impaired nitric oxide (NO) production and chronic inflammation. Biomechanical forces on the endothelium, including low shear stress from disturbed blood flow and hypertension, are also important causes of endothelial dysfunction. These processes seem to be augmented in patients with Diabetes. In states of insulin resistance and in type 2 Diabetes insulin signalling is impaired. Increased vascular inflammation, including enhanced expression of inter-leukin-6 (IL-6), vascular cellular adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein (MCP-1) are observed, as is a marked decrease in NO bioavail-ability. Furthermore, hyperglycaemia leads to increased formation of advanced glycation end products (AGE), which quench NO and impair endothelial function. In summary, during the development of diabetes a number of biochemical and mechanical factors converge on the endothelium, resulting in endothelial dysfunction and vascular inflammation. In the presence of insulin resistance, these processes are potentiated and they provide a basis for the macrovascular disease seen in diabetes.Keywords
This publication has 61 references indexed in Scilit:
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Obesity-Associated HypertensionHypertension, 2005
- Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive TreatmentHypertension, 2004
- Treatment of hypertension with ascorbic acidThe Lancet, 1999
- Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Diabetes Mellitus and Associated Hypertension, Vascular Disease, and NephropathyHypertension, 1995
- Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.JCI Insight, 1994
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Inhibition of platelet-derived mitogen release by nitric oxide (EDRF)Inflammation Research, 1989
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980